Gabe Chamie, MD, MPH

Assistant Adjunct Professor, HIV/AIDS Division, Department of Medicine, UCSF


E-mail Address:  Gabriel.Chamie@ucsf.edu

 

Gabe Chamie

Research Interests:
TB/HIV co-infection

 

Education and Training:
Yale University, New Haven, CT, BA, 1994-1998

Stanford Medical School, Palo Alto, CA, MD, 1999-2003

University of California, San Francisco, Residency, Internal Medicine, 2003-2007

University of California, Post-doctoral fellow, Infectious Diseases Fellowship, San Francisco, 2007

University of California, San Francisco, Post-doctoral fellow, Training in AIDS Prevention Studies, 2008

Univerisity of California, MPH, Epidemiology, Berkeley, 2008

 

Key Publications:


1. Jain V, Liegler T, Kabami J, Chamie G, Clark TD, Black D, Geng EH, Kwarisiima D, Wong JK, Abdel-Mohsen M, Sonawane N, Aweeka FT, Thirumurthy H, Petersen ML, Charlebois ED, Kamya MR, Havlir DV; for the SEARCH Collaboration.Assessment of Population-Based HIV RNA Levels in a Rural East African Setting Using a Fingerprick-Based Blood Collection Method. Clin Infect Dis. 2012 Dec 12. [Epub ahead of print] PMID: 23243180


2. Thirumurthy H, Chamie G, Jain V, Kabami J, Kwarisiima D, Clark TD, Geng E, Petersen ML, Charlebois ED, Kamya MR, Havlir DV; and the SEARCH Collaboration. Improved employment and education outcomes in households of HIV-infected adults with high CD4 counts: evidence from a community health campaign in Uganda. AIDS. 2012 Nov 19. [Epub ahead of print]. PMID: 23169332


3. Chamie G, Kwarisiima D, Clark TD, Kabami J, Jain V, Geng E, Petersen ML, Thirumurthy H, Kamya MR, Havlir DV, Charlebois ED; SEARCH Collaboration. Leveraging rapid community-based HIV testing campaigns for non-communicable diseases in rural Uganda. PLoS One. 2012;7(8):e43400. Epub 2012 Aug 20. PMID: 22916256


4. Luetkemeyer AF, Getahun H, Chamie G, Lienhardt C, Havlir DV.Tuberculosis drug development: ensuring people living with HIV are not left behind. Am J Respir Crit Care Med. 2011 Nov 15;184(10):1107-13. doi: 10.1164/rccm.201106-0995PP. Epub 2011 Aug 25. PMID: 21868507


5. Chamie G, Luetkemeyer A, Walusimbi-Nanteza M, Okwera A, Whalen CC, Mugerwa RD, Havlir DV, Charlebois ED.Significant variation in presentation of pulmonary tuberculosis across a high resolution of CD4 strata. Int J Tuberc Lung Dis. 2010 Oct;14(10):1295-302. PMID: 20843421


6. Chamie G, Charlebois ED, Srikantiah P, Walusimbi-Nanteza M, Mugerwa RD, Mayanja H, Okwera A, Whalen CC, Havlir DV.Mycobacterium tuberculosis microbiologic and clinical treatment outcomes in a randomized trial of immediate versus CD4(+)-initiated antiretroviral therapy in HIV-infected adults with a high CD4(+) cell count. Clin Infect Dis. 2010 Aug 1;51(3):359-62. doi: 10.1086/654799. PMID: 20569064


7. Chamie G, Luetkemeyer A, Charlebois E, Havlir DV. Tuberculosis as part of the natural history of HIV infection in developing countries.Clin Infect Dis. 2010 May 15;50 Suppl 3:S245-54. doi: 10.1086/651498. Review. PMID: 20397955


8. Bhave P, Chamie G.Streptococcus pneumoniae keratitis. J Hosp Med. 2008 Jul;3(4):353. doi: 10.1002/jhm.306. PMID: 18698596


9. Chamie G, Bonacini M, Bangsberg DR, Stapleton JT, Hall C, Overton ET, Scherzer R, Tien PC. Factors associated with seronegative chronic hepatitis C virus infection in HIV infection. Clin Infect Dis. 2007 Feb 15;44(4):577-83. Epub 2007 Jan 10. PMID: 17243063